Islam Hamad

2.7k total citations
33 papers, 1.3k citations indexed

About

Islam Hamad is a scholar working on Biomaterials, Biomedical Engineering and Immunology. According to data from OpenAlex, Islam Hamad has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 8 papers in Biomedical Engineering and 7 papers in Immunology. Recurrent topics in Islam Hamad's work include Nanoparticle-Based Drug Delivery (7 papers), Complement system in diseases (7 papers) and Advanced Drug Delivery Systems (6 papers). Islam Hamad is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Complement system in diseases (7 papers) and Advanced Drug Delivery Systems (6 papers). Islam Hamad collaborates with scholars based in Jordan, Denmark and United Kingdom. Islam Hamad's co-authors include S. Moein Moghimi, A. Christy Hunter, János Szebeni, Thomas L. Andresen, K. J. Rutt, Kent Jørgensen, Othman Al-Hanbali, Yasser Bustanji, Zhuang Liu and Alina J. Andersen and has published in prestigious journals such as ACS Nano, The FASEB Journal and Journal of Controlled Release.

In The Last Decade

Islam Hamad

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Islam Hamad Jordan 16 616 445 321 269 217 33 1.3k
Zhirong Zhong China 24 345 0.6× 766 1.7× 350 1.1× 199 0.7× 159 0.7× 59 1.7k
Güneş Esendağlı Türkiye 27 555 0.9× 569 1.3× 356 1.1× 628 2.3× 238 1.1× 94 2.0k
Casimiro Luca Gigliotti Italy 26 446 0.7× 573 1.3× 337 1.0× 401 1.5× 269 1.2× 53 1.8k
Songling Han China 20 413 0.7× 476 1.1× 497 1.5× 149 0.6× 111 0.5× 46 1.5k
Chunrong Yang China 25 538 0.9× 945 2.1× 730 2.3× 190 0.7× 139 0.6× 81 1.9k
Chenwen Li China 23 623 1.0× 457 1.0× 533 1.7× 180 0.7× 145 0.7× 46 1.8k
Upendra Bulbake India 10 787 1.3× 905 2.0× 525 1.6× 261 1.0× 403 1.9× 12 1.9k
Hasan Ebrahimi Shahmabadi Iran 24 539 0.9× 312 0.7× 412 1.3× 95 0.4× 184 0.8× 63 1.3k
Yongxing Zhao China 21 364 0.6× 958 2.2× 419 1.3× 148 0.6× 252 1.2× 55 1.7k
Nidhi Raval India 16 583 0.9× 511 1.1× 608 1.9× 97 0.4× 149 0.7× 25 1.4k

Countries citing papers authored by Islam Hamad

Since Specialization
Citations

This map shows the geographic impact of Islam Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Islam Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Islam Hamad more than expected).

Fields of papers citing papers by Islam Hamad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Islam Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Islam Hamad. The network helps show where Islam Hamad may publish in the future.

Co-authorship network of co-authors of Islam Hamad

This figure shows the co-authorship network connecting the top 25 collaborators of Islam Hamad. A scholar is included among the top collaborators of Islam Hamad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Islam Hamad. Islam Hamad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alshaer, Walhan, Zainab Lafi, Hamdi Nsairat, et al.. (2025). Remote Co-Loading of Doxorubicin and Hydralazine into PEGylated Liposomes: In Vitro Anti-Proliferative Effect Against Breast Cancer. Molecules. 30(7). 1549–1549. 1 indexed citations
2.
Jaber, Nisrein, et al.. (2024). Dual stimuli-responsive polymeric nanoparticles combining soluplus and chitosan for enhanced breast cancer targeting. RSC Advances. 14(5). 3070–3084. 22 indexed citations
3.
Bustanji, Yasser, Waseem El‐Huneidi, Mohammad H. Semreen, et al.. (2023). Analysis and mapping of global scientific research on human monkeypox over the past 20 years. Veterinary World. 693–703. 6 indexed citations
5.
Almaliti, Jehad, Muhammed Alzweiri, C. Benjamin Naman, et al.. (2022). Discovery of Novel Epoxyketone Peptides as Lipase Inhibitors. Molecules. 27(7). 2261–2261. 4 indexed citations
7.
Zalloum, Waleed A., Ayman Khdair, Islam Hamad, et al.. (2021). Novel in vitro and in vivo anti-Helicobacter pylori effects of pomegranate peel ethanol extract. Veterinary World. 14(1). 120–128. 26 indexed citations
8.
Habashneh, Rola Al, et al.. (2021). Efficacy of serratiopeptidase after impacted third molar surgery: a randomized controlled clinical trial. BMC Oral Health. 21(1). 91–91. 8 indexed citations
9.
Alkilani, Ahlam Zaid, et al.. (2019). Knowledge, attitude, practice and satisfaction of patients using analgesic patches in Jordan. Tropical Journal of Pharmaceutical Research. 18(8). 1745–1753. 2 indexed citations
10.
Hamad, Islam, et al.. (2018). Effects of dairy and supplemental calcium on food intakes in a group of Jordanian females. Progress in nutrition. 20(2). 229–235.
11.
Khdair, Ayman, Islam Hamad, Hatim S. AlKhatib, et al.. (2016). Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin. European Journal of Pharmaceutical Sciences. 93. 38–44. 68 indexed citations
12.
Hamad, Islam, et al.. (2015). Effect of the Lubricant Magnesium Stearate on Changes of Specific Surface Area of Directly Compressible Powders Under Compression. Jordan Journal of Pharmaceutical Sciences. 8(1). 2 indexed citations
13.
Khdair, Ayman, et al.. (2013). In Vitro Artificial Membrane-Natural Mucosa Correlation of Carvedilol Buccal Delivery. Journal of Drug Delivery Science and Technology. 23(6). 603–609. 13 indexed citations
14.
Hamad, Islam, A. Christy Hunter, & S. Moein Moghimi. (2013). Complement monitoring of Pluronic 127 gel and micelles: Suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100. Journal of Controlled Release. 170(2). 167–174. 35 indexed citations
15.
Moghimi, S. Moein, Alina J. Andersen, Sayed Hossein Hashemi, et al.. (2010). Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: The challenges ahead. Journal of Controlled Release. 146(2). 175–181. 137 indexed citations
16.
Hamad, Islam, A. Christy Hunter, K. J. Rutt, et al.. (2008). Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Molecular Immunology. 45(14). 3797–3803. 88 indexed citations
17.
Hamad, Islam & S. Moein Moghimi. (2008). Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug. Expert Opinion on Drug Delivery. 5(2). 205–219. 32 indexed citations
18.
Hamad, Islam, A. Christy Hunter, János Szebeni, & S. Moein Moghimi. (2008). Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process. Molecular Immunology. 46(2). 225–232. 200 indexed citations
19.
Moghimi, S. Moein & Islam Hamad. (2008). Liposome-Mediated Triggering of Complement Cascade. Journal of Liposome Research. 18(3). 195–209. 63 indexed citations
20.
Moghimi, S. Moein, Islam Hamad, Rolf Bünger, et al.. (2006). Activation of the Human Complement System by Cholesterol-Rich and PEGylated Liposomes—Modulation of Cholesterol-Rich Liposome-Mediated Complement Activation by Elevated Serum LDL and HDL Levels. Journal of Liposome Research. 16(3). 167–174. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026